Recent Finacing
Recent Raise
Nosopharm is a Lyon-based biotechnology company that discovers and develops odilorhabdin-class antibiotics (e.g., NOSO-502/NOSO-95179) from Xenorhabdus/Photorhabdus-derived natural products for multidrug-resistant hospital-acquired infections, with medicinal chemistry and preclinical development capabilities.
